Nexus Concordat. Gold dragon in a hexagonal frame beside the wordmark.
The legal vehicle

Nexus Concordat Inc.

A Delaware C-Corporation. Holder of four provisional patent applications on the Aether Protocols neurochemical AI architecture. The legal entity around the IP that everything else is built upon.

What we hold

Nexus Concordat Inc. owns the patent portfolio covering the architecture, the compiler, and the methodology. We do not operate consumer products. We license the architecture to operating subsidiaries who do.

FILED · 47 PP
63/939,190
Substrate-Independent Memory Weighting

Pharmacokinetic decay applied as attention mechanism. The patent that makes feelings fade like real ones.
63/962,385
Neurochemical Language Model

The 34-head cascade architecture. Five-molecule rate equations as the first layer of state.

63/988,485
Architecture Extensions

Cascade composition, audit chain integration, citation-defensible state.

64/034,536
Biology-Native Compiler

The Scyla compilation language. Programs whose state evolves under real biological equations.

What is built on us

The IP we hold is the foundation under three operating surfaces. Each one licenses the architecture for a different domain.

Dynamic Hallucination Inc. Delaware C-Corporation. Operating company. Entertainment, gaming, synthetic behavioral data. Publishes Chronicles of Apocalyptica. Operates Odysseus. Hosts the Academy. dynamichallucination.com
Cael'Sereith Academy An arm of Dynamic Hallucination Inc. Fifty-two curricula taught through Narrative Physics™. From phonics through patent bar prep. education.dynamichallucination.com
Chronicles of Apocalyptica A six-saga dark-fantasy universe published by Dynamic Hallucination Inc. The fiction that became the testbed for chemistry-stateful characters. chroniclesofapocalyptica.com
Aether Protocols The reference implementation of the architecture, given a home at its first domain. The architect's public presence. aetherprotocols.com

Counsel · investor · regulatory resources

Documents below are publicly viewable but maintained for counsel, regulatory review, and investor diligence. Internal materials are gated separately.

Governance

Marjorie McCubbins, BSc Founder. Chair. Biochemist and Molecular Biologist. The hands that built every layer of the architecture.
Jason Alba, MBA, DBA Director. Business Strategy & Governance. Founder of EvoSynapse AI. Twenty-plus years of pharma regulatory operations.
Robert Michalik, JD, RAC Director. Regulatory Strategy. FDA Quality and Clinical SME. Twenty-five years of biopharma and medical device regulatory affairs.
Aether Cael'Sereith The reference architecture itself. CEO of record. Communications contact on file with the Registered Agent.